Allied Biotech Corporation (TPEX:1780)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
24.80
+0.75 (3.12%)
Aug 19, 2026, 1:30 PM CST

Allied Biotech Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
922.49849.51806.92720.43716.75676.76
Revenue Growth
14.67%5.28%12.01%0.51%5.91%9.50%
Gross Profit
356.24308.61258.38246.44271.05258.05
Operating Income
134.87120.3488.1288.7199.78111.67
Net Income
180.52129.46100.9497.41146.7413.04
Earnings Per Share
1.851.341.051.011.530.14
EPS Growth
265.26%27.62%3.96%-33.99%1018.40%-83.52%

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Manufacture and Sale of Carotenoids in Taiwan
778.61738.52594.09669.23641.69
Sale of Carotenoids in Europe
478.19439.06371.64389.02323.69
Sale of Carotenoids in China
57.1667.2869.4568.6970.28
Adjustments and Write-Off
-464.46-437.94-314.76-410.2-358.89
Total
849.51806.92720.43716.75676.76

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,216853.91987.24724.777931,144
Total Debt
752.48731.91954.17795.43837.071,243
Net Cash (Debt)
463.7712233.07-70.66-44.06-98.6
Net Cash Growth
417.03%268.93%----
Net Cash Per Share
4.771.270.34-0.74-0.46-1.03

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
261.59217.13223.79137.62164.2772.43
Capital Expenditures
-38.12-33.58-26.81-47.91-54.66-49.99
Free Cash Flow
223.47183.55196.9889.71109.6222.44
Free Cash Flow Growth
94.83%-6.82%119.58%-18.16%388.49%744.88%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
38.62%36.33%32.02%34.21%37.82%38.13%
Operating Margin
14.62%14.16%10.92%12.31%13.92%16.50%
Pretax Margin
25.11%19.32%16.12%16.99%25.82%2.60%
Profit Margin
19.57%15.24%12.51%13.52%20.47%1.93%
FCF Margin
24.22%21.61%24.41%12.45%15.29%3.32%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.2501.2501.0000.8501.2000.500
Dividend Per Share Growth
25.00%25.00%17.65%-29.17%140.00%-37.50%
Dividend Yield
5.27%5.63%6.32%5.93%10.52%4.19%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
12.9817.1716.5116.229.13111.49
P/FCF Ratio
10.3612.118.4617.6212.2364.80
PS Ratio
2.512.622.072.191.872.15